James A. Robinson Jr.

Insider Reports History

Location
852 Winter Street, Waltham, MA
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James A. Robinson Jr.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. Director Stock Option (right to buy) 30.9K $233K $1.55 Jan 10, 2035 Direct
UroGen Pharma Ltd. Director Stock Option (right ot buy) 10K Aug 26, 2025 Direct
UroGen Pharma Ltd. Director Restricted Stock Unit 8K Aug 26, 2025 Direct
Eledon Pharmaceuticals, Inc. Director Restricted Stock Units 3.43K Jan 10, 2025 Direct
APPLIED GENETIC TECHNOLOGIES CORP Director Stock Option (Right to Buy) 0 Nov 30, 2022 Direct

Insider Reports Filed by James A. Robinson Jr.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
URGN UroGen Pharma Ltd. Aug 26, 2025 2 $0 4 Aug 27, 2025 Director
ELDN Eledon Pharmaceuticals, Inc. Jan 10, 2025 2 $0 4 Jan 13, 2025 Director
URGN UroGen Pharma Ltd. Aug 6, 2024 1 $0 4 Aug 8, 2024 Director
ELDN Eledon Pharmaceuticals, Inc. Oct 2, 2023 1 $233K 4 Oct 3, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. Oct 1, 2023 0 $0 3 Oct 2, 2023 Director
URGN UroGen Pharma Ltd. Sep 7, 2023 1 $0 4 Sep 8, 2023 Director
URGN UroGen Pharma Ltd. Jul 25, 2023 1 $0 4/A Jul 28, 2023 Director
URGN UroGen Pharma Ltd. Jul 25, 2023 0 $0 3 Jul 27, 2023 Director
AGTC APPLIED GENETIC TECHNOLOGIES CORP Nov 30, 2022 1 $0 4 Dec 1, 2022 Director
AGTC APPLIED GENETIC TECHNOLOGIES CORP Nov 30, 2021 1 $0 4 Dec 2, 2021 Director
AGTC APPLIED GENETIC TECHNOLOGIES CORP Nov 30, 2021 0 $0 3 Dec 2, 2021 Director